Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 2 art units • 2 examiners • 0 of 3 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Shanghai Aucta Pharmaceuticals Co. Ltd. has 3 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 2 distinct examiners across 2 distinct art units, so at least one examiner handles more than one current matter while the art-unit assignments remain differentiated.
TRAN, SUSAN T is the busiest examiner, with 2 pending matters. Those matters warrant coordinated review for shared prosecution issues, followed by responses tailored to the relevant applications and art units.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §102 only | 2 (67%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TRAN, SUSAN T | 2 | 63.0% | +34.8% |
| MOU, LIYUAN | 1 | 43.8% | +59.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19033064 | A PHARMACEUTICAL KIT FOR PREPARATION OF READY-TO-USE VIGABATRIN SOLUTION | MOU, LIYUAN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19048739 | PHARMACEUTICAL DOSAGE FORM OF LACOSAMIDE | TRAN, SUSAN T | — |
| 19033064 | A PHARMACEUTICAL KIT FOR PREPARATION OF READY-TO-USE VIGABATRIN SOLUTION | MOU, LIYUAN | — |
| 18779285 | LACOSAMIDE PHARMACEUTICAL COMPOSITION AND DOSAGE FORM THEREOF | TRAN, SUSAN T | — |
| Art Unit | Apps |
|---|---|
| 1628 | 1 |
| 1615 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19048739 | PHARMACEUTICAL DOSAGE FORM OF LACOSAMIDE | TRAN, SUSAN T | — | §102Other | Non-Final OA | — | Pending | Feb 07, 2025 |
| 19033064 | A PHARMACEUTICAL KIT FOR PREPARATION OF READY-TO-USE VIGABATRIN SOLUTION | MOU, LIYUAN | 1628 | §103§112 | Non-Final OA | — | Pending | Jan 21, 2025 |
| 18779285 | LACOSAMIDE PHARMACEUTICAL COMPOSITION AND DOSAGE FORM THEREOF | TRAN, SUSAN T | 1615 | §102Other | Non-Final OA | — | Pending | Jul 22, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialShanghai Aucta Pharmaceuticals Co. Ltd. has 3 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Susan T Tran has the most, with 2 of Shanghai Aucta Pharmaceuticals Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
